Key facts
- It has raised $33.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Dalton Venture, Shenzhen Yifeng Investment Management Enterprise, Furong Capital, Suzhou Asset Management, Guangzhou Jinkong Fund — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Shineyo Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Shineyo Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shineyo Medical
Developer of medical devices designed to advance the treatment of cardiac electrophysiology and peripheral vascular conditions. The company offers self-developed active medical devices, vascular intervention catheters, and biomedical material technologies, enabling healthcare providers to offer innovative treatments for atrial fibrillation, varicose veins, and pulmonary embolism, while filling a domestic gap in medical device innovation.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Employees
- 86
- Website
- shineyomedical.com/
- Ownership
- Privately Held (backing)
Shineyo Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shineyo Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shineyo Medical in its N-PORT filings yet. We sweep new filings monthly.